Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical efficacy of sofosbuvir/daclatasvir in patients with COVID-19: a systematic review and meta-analysis of randomized trials.

Expert review of clinical pharmacology - 1 Aug 2022

Chen Chao-Kun, Weng Teng-Song, Chen Yu-Hung, Kao Jui-Heng, Chao Chien-Ming

Abstract excerpt

BACKGROUND: This study investigated the clinical efficacy sofosbuvir/daclatasvir (SOF-DCV) in patients with COVID-19. RESEARCH DESIGN AND METHODS: PubMed, Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases were searched for relevant articles written before January 6, 2022. Only randomized controlled trials (RCTs) comparing the clinical efficacy of SOF-DCV (study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamates
Share to COVID-19 Drug Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Imidazoles

Share to Pyrrolidines

Share to Randomized Controlled Trials as Topic

Share to Sofosbuvir

Share to Valine

Source

Identifiers

PMID: 35852099
DOI: 10.1080/17512433.2022.2103539

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical efficacy of sofosbuvir/daclatasvir in patients with COVID-19: a systematic review and meta-analysis of randomized trials.PMID 35852099Read ↗

Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID-19: A randomized controlled trial.Semantic proximity Read ↗

Evaluation of the Effect of Sofosbuvir and Daclatasvir in Hospitalised COVID-19 Patients: A Randomized Double-Blind Clinical Trial (DISCOVER)Semantic proximity Read ↗

Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals.Semantic proximity Read ↗

Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysisSemantic proximity Read ↗

The efficacy and safety of Favipiravir in treatment of COVID-19: A systematic review and meta-analysis of clinical trialsSemantic proximity Read ↗

Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity Read ↗

Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity Read ↗

Efficacy of Sofosbuvir plus Ledipasvir in Egyptian patients with COVID-19 compared to standard treatment: a randomized controlled trial.Semantic proximity Read ↗

Efficiency of antiviral treatment in COVID‑19Semantic proximity Read ↗

Effectiveness of REGEN-COV Antibody Combination in Preventing Severe COVID-19 OutcomesSemantic proximity Read ↗

Outcomes evaluated in controlled clinical trials on the management of COVID-19: A methodological systematic reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.